Group C and G Streptococcal Pharyngitis Does Not Require Antibiotic Treatment
Positive throat cultures for group C or G streptococcus should NOT be routinely treated with antibiotics, as all major clinical guidelines focus exclusively on Group A streptococcus (GAS) as the only bacterial pharyngitis requiring antibiotic therapy.
Why Guidelines Don't Support Treatment
The IDSA guidelines from 1997,2002, and 2012 1, 2, 3, 4 consistently define streptococcal pharyngitis requiring treatment as infection specifically with Streptococcus pyogenes (Group A streptococcus). The primary rationale for treating bacterial pharyngitis with antibiotics is prevention of acute rheumatic fever, suppurative complications, and reduction of transmission—outcomes proven only for Group A streptococcus 2.
Groups C and G streptococci are not associated with acute rheumatic fever, which is the most serious complication driving antibiotic treatment decisions for pharyngitis 5. While these organisms can cause pharyngitis and rarely reactive arthritis 5, the evidence shows that prophylactic measures effective for GAS-associated sequelae are not effective for group C/G associated infections 5.
Clinical Approach
When you encounter a positive throat culture for group C or G streptococcus:
- Treat symptomatically with analgesics (acetaminophen, NSAIDs) or throat lozenges 1, 6
- Do not prescribe antibiotics unless there are specific concerning features suggesting invasive disease
- Reassure the patient that most pharyngitis is self-limited, resolving in less than one week 6
Important Caveats
Consider antibiotic treatment only in these specific scenarios:
- Signs of invasive infection (severe systemic symptoms, inability to swallow, neck swelling, or signs of deep tissue infection) 7
- Immunocompromised patients where group C/G streptococci can cause serious invasive disease 7
- Documented outbreak situations in closed communities
The research evidence confirms that groups C and G streptococci are susceptible to penicillin 8, but susceptibility does not equal indication for treatment. These organisms are increasingly recognized as emerging pathogens causing invasive infections primarily in patients with severe underlying medical conditions 7, but routine pharyngitis does not warrant treatment.
Common Pitfall to Avoid
Do not reflexively treat all positive streptococcal throat cultures. The presence of group C or G streptococcus may represent colonization rather than true infection, particularly if viral symptoms (cough, rhinorrhea, hoarseness) are present 1. Testing should be reserved for patients meeting clinical criteria suggestive of bacterial pharyngitis (fever, tonsillar exudates, tender anterior cervical adenopathy, absence of cough) 6, 9.
The 2016 ACP/CDC guidelines emphasize that even for confirmed Group A streptococcal infection, antibiotics provide only modest symptom benefit (shortening sore throat by 1-2 days, with number needed to treat of 6 at 3 days) 6. For group C/G streptococci, where there is no evidence of preventing serious complications, the risk-benefit ratio of antibiotics is even less favorable.